OC18 Is it safe to diagnose coeliac disease using the no-biopsy pathway for those with TGA-IgA ≥5x upper limit of normal: a regional study from Southwest England?

V Gangalam; D Basude; H Khattak; C Knight; L Tashtoush; S Broad; N Zurick; S Paul

doi:10.1136/flgastro-2023-bspghan.18

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

CME/CPD

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Abstracts

OC18 Is it safe to diagnose coeliac disease using the no-biopsy pathway for those with TGA-IgA ≥5x upper limit of normal: a regional study from Southwest England?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Gangalam V, Basude D, Khattak H, et al

OC18 Is it safe to diagnose coeliac disease using the no-biopsy pathway for those with TGA-IgA ≥5x upper limit of normal: a regional study from Southwest England?

Frontline Gastroenterology 2023;14:A13-A14.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password